CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
Sulfadoxine-pyrimethamine/folic acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00130065
NCT00130065Phase 4Completed
CompareCT.gov

The Effect of Folic Acid Supplementation on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenya

Centers for Disease Control and Prevention·interventional·Posted Aug 15, 2005·Updated Sep 27, 2012

In Brief

A Phase 4 clinical trial evaluating Sulfadoxine-pyrimethamine/folic acid and Sulfadoxine-pyrimethamine/placebo for Malaria. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine whether folic acid, which is often routinely given to pregnant women to prevent birth defects and anemia, affects the efficacy of sulfadoxine-pyrimethamine, another drug that is routinely given to pregnant women in highly malarious areas, for prevention of the adverse effects of malaria during pregnancy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria
CountriesKenya
CollaboratorsKenya Medical Research Institute, Kenya Ministry of Health

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 15, 2005
Enrollment StartNov 1, 2003
Primary CompletionFeb 1, 2006
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 20.9 years ago

Interventions

Sulfadoxine-pyrimethamine/folic aciddrug

Sulfadoxine-pyrimethamine/placebodrug